AdvaMed Names GE HealthCare Leader Peter J. Arduini as Chairman

AdvaMed, the Advanced Medical Technology Association, has named GE HealthCare president and CEO Peter J. Arduini as its next chair of the board.
 
Arduini had stepped in to serve as interim chair over the past few weeks in the wake of former Ashley McEvoy’s departure from Johnson & Johnson MedTech in October. The board elected him to a two-year term, which began on Friday.
 
“The entire board and the global industry AdvaMed represents are very excited to have Peter as our new Board Chair during this critical time for medtech. Artificial Intelligence, imaging and digital technology represent important areas of innovation that can significantly accelerate diagnosis and improve the personalization of patient care. Peter’s proven record of leadership across more than three decades in medtech and imaging will enable him to advance AdvaMed’s goal of achieving healthier lives and healthier communities around the world. I look forward to working with him,” said AdvaMed President and CEO Scott Whitaker, who also serves as President of the AdvaMed Board of Directors.
 
Arduini has been president and CEO of GE HealthCare since January 2022. Before that, he was president and CEO of Integra LifeSciences, and was corporate VP and president of Medication Delivery for Baxter Healthcare from 2005 to 2010.
 
Arduini said, “I appreciate the confidence my fellow AdvaMed Board members have placed in me as the Board’s new chair. Through Scott’s leadership, AdvaMed has become a unifying voice for our industry to foster growth and innovative new solutions for patients, providers and health systems. The medical technology industry is at the forefront of defining the future of healthcare through smart devices, diagnostics and digital solutions that can enable earlier and more precise diagnoses, targeted treatments and improved patient outcomes. We need policies that keep pace with innovation, while fostering the highest ethical standards that improve patient access to the best care possible. With the promise of artificial intelligence and the interconnectivity of medical technologies, there has never been a more important time in our history to make profound and lasting changes in the delivery of care for patients.”
 
Arduini will reveal his priorities as AdvaMed chair in early 2024, the association said.